MedTrace Logo

Microbubbles and Ultrasound in Stroke Trial: MUST Study

NCT00222040 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2010-04-30

No results posted yet for this study

Summary

To determine whether transcranial 2-MHz ultrasound combined with intravenous administration of microbubbles improves early recanalization in patients with acute ischemic stroke caused by middle cerebral artery (MCA) proximal occlusion treated with intravenous alteplase within 3 hours of symptom onset.

Conditions

  • Acute Ischemic Stroke

Interventions

RADIATION

Ultrasound

2-MHz, low intensity transcranial ultrasound

DRUG

Levovist

D-Galactose and palmitic palmitique intravenous 4 g

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • LARRUE Vincent, MD · University Hospital, Toulouse, France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2004-06-30
Completion
2004-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00222040 on ClinicalTrials.gov